Ovarian
cancer is a huge problem in women's health. Known as a ‘silent killer’
because the early stages of the disease rarely exhibit symptoms and
growths in the ovary are not palpable as other, for example breast,
cancers may be. About 75% of ovarian cancers are not detected until
after the disease has spread to the abdomen and more than 50% of
patients die within 5 years of diagnosis. The study with Singapore
General Hospital will be a pilot study – Singapore General Hospital will
provide samples from 40 subjects and we will analyze them to assess the
ability of our
NuQ tests to detect ovarian cancer. We hope that, given
positive results from the pilot study, we will be able to expand into
further confirmatory trials in larger numbers of patients.......
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.